NCT06538116: A Study of Mevidalen (LY3154207) in Participants With Alzheimer's Disease
- State
- Completed
- Phase
- Phase 2
- People
- 304 taking part
- Started
- 26 Aug 2024
- Primary completion
- 1 May 2026
- Arms
- Mevidalen (high dose), Mevidalen (low dose)
- Results
- None posted
- 5 Aug 2024: Trial registered
- 26 Aug 2024: Trial started
- 11 May 2026: Trial completed